Oncotarget is a free access medical journal reviewed insightfully on weekly basis. Founded in 2010 and printed by Impact Journals, its papers covers study on all features oncology. Printed paper orissue is usually done on a special request. Oncotarget mission is to fasten the availability of scientific outcomes by capitalizing on the influence of research. To break the barrier between specialties and permittingrapid sharing of extraordinary discoveries. To bond diverse biomedical science fields as well as nurturing the use of clinical and basic science in fighting diseases.
Oncotarget operates under the leadership of dozens of highly skilled scientists whose researchplays part in the advancement of science. The medical journal has been experiencing tremendous growth enabling it to initiates sections further than oncology. The proficient personnel also aids in crafting the journal so as to deliver credible issue-based information. Download output styles at Endnote.com.
Editor-in –Chiefs’ Role in Cancer Treatment
Two most devoted chief editors, Mikhail V. Blagosklonny and Andrei V. Gudkov who are both medical scientists at Roswell Park Cancer Institute, based in Buffalo, New Yorkhave been key figures behind Oncotarget’s progress. Mikhail specializes on clinical investigation, molecular and cellular biology, signal transduction, cell cycle studies and cellular senescence. He is also passionate on anticancer therapeutics, finding new tactics of cancertreatment by use of basic science. He initiated a theory on the use of signal transduction pathways which is a good anti-aging remedy. Mikhail graduated from St. Petersburg’s First Pavlov State Medical University with both PhD in experimental medicine and cardiology, as well as M.D. in internal medicine. On the other hand, Gudkov, focusses on the new drugs discovery that be used in gene discovery, treatment of cancer as well as learning how to treat cancer by use of molecular targets. He is a National Cancer Center and Moscow State University graduate.
Enhancing Satisfaction and Quality life of Patients
The journal also emphasizes on management programs effect and new therapeutic personnel and procedures on patient point of view such as fulfilment, adherence and quality of life. It also brings to light the proof behind existing and latest treatments on its recommended usage and the positive results. Oncotarget final objective is to ensure quality life with no disease. Learn more about Oncotarget at researchgate.net